Evaluation of A Clinical Diagnostic Test for CRDS
Conditions: Calcium Release Deficiency Syndrome (CRDS) Interventions: Diagnostic Test: Pacing Sponsors: Population Health Research Institute; Canadian Institutes of Health Research (CIHR) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
A Nutrition and Exercise Lifestyle Intervention Program Participant Choice Approach
Conditions: Lifestyle, Healthy; Pregnancy Related; Adherence, Treatment; Nutrition, Healthy; Weight Gain, Maternal Interventions: Behavioral: Nutrition and Exercise Lifestyle Intervention Program Sponsors: Western University, Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
The STOP-MED CTRCD Trial
Conditions: Heart Failure; Cardiotoxicity; Cardiac Toxicity; Antineoplastics Toxicity; Cancer Interventions: Other: Stopping Heart Failure Medication(s) Sponsors: University Health Network, Toronto; Unity Health Toronto; Hamilton Health Sciences Corporation; St. Boniface Hospital; University of Alberta; University of Ottawa Heart Institute, Canada; University College London Hospitals; Alberta Health Services, Calgary; Brigham and Women ' s Hospital; Baker Heart and Diabetes Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Drug: Daratumumab; Drug: Lenalidomide; Drug: Dexamethasone Sponsors: Canadian Cancer Trials Group; Canadian Institutes of Health Research (CIHR); Myeloma Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Canagliflozin in Advanced Renal Disease With MRI Endpoints
Conditions: ESRD, CKD Stage 4, CKD Stage 5 Interventions: Drug: Canagliflozin 300Mg Tab; Drug: Placebo Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Heart and Stroke Foundation of Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
Conditions: Arrhythmogenic Cardiomyopathy; Arrhythmogenic Right Ventricular Cardiomyopathy Interventions: Drug: Tideglusib; Drug: Placebo Sponsors: Hamilton Health Sciences Corporation; Population Health Research Institute; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Emphasys Radiostereometric Analysis
Conditions: Hip Osteoarthritis Interventions: Device: Emphasys Hip Solutions Sponsors: Canadian Radiostereometric Analysis Network; DePuy Synthes Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
e-IMPAQc Systematic Assessment of Patient Reported Outcomes in Cancer Care
Conditions: Cancer Interventions: Other: eIMPAQc Sponsors: St. Mary ' s Research Center, Canada Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Implementing Individualized Patient Reported Outcome Measures in Routine Care of Patients With Coronary Artery Disease
Conditions: Coronary Artery Disease; Patient Acceptance of Health Care; Physician-Patient Relations Interventions: Other: ePROM Survey Sponsors: University of Calgary; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Merck Announces Findings from Phase 2 KeyVibe-002 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
RAHWAY, N.J.--(BUSINESS WIRE) December 7, 2023 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced full results from the non-registrational Phase 2 KeyVibe-002 trial evaluating vibostolimab/pembrolizumab, an... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 7, 2023 Category: Pharmaceuticals Source Type: clinical trials
Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain
Conditions: Acute Pain; Abdomen, Acute; Abdominal Pain; Appendicitis; Emergencies; Child, Only Interventions: Drug: Ketorolac Tromethamine; Drug: Morphine Sulfate; Drug: normal saline; Drug: Normal saline Sponsors: University of Calgary; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
The Effect of Chiropractic Care on Opioid Use for Chronic Spinal Pain: A Feasibility Study
Conditions: Back Pain Interventions: Other: Usual Medical Care; Other: Usual Medical Care + Chiropractic Care Sponsors: McMaster University; Surgical Methods Centre, McMaster University; Michael G. DeGroote Institute for Pain Research and Care; Ontario Chiropractic Association; Alliance for Healthier Communities; Michael G. DeGroote National Pain Centre; Canadian Chiropractic Research Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Bootle Blast: Understanding the Family Experience
Conditions: Cerebral Palsy; Developmental Coordination Disorder; Developmental Disability; Autism Spectrum Disorder; Spinal Cord Injuries; Stroke; Acquired Brain Injury; Motor Skills Disorders Interventions: Device: Bootle Blast Play Phase (B) Sponsors: Holland Bloorview Kids Rehabilitation Hospital; Canadian Institutes of Health Research (CIHR) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
Conditions: Hepatic Disease; Surgery-Complications; Hypercoagulability; Thrombosis Interventions: Drug: Redesca (enoxaparin sodium for injection); Drug: Fragmin (dalteparin) Sponsors: Western University, Canada; Valeo Pharma Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Older Adults With Cognitive Impairment Doing Sit to Stands, Walking in Transitional Care Programs: A Feasibility Study
Conditions: Cognitive Impairment; Dementia; Delirium; Functional Decline Interventions: Other: OASIS Walking Intervention Sponsors: University Health Network, Toronto; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
